162 results
424B5
LXRX
Lexicon Pharmaceuticals Inc
29 Dec 23
Prospectus supplement for primary offering
5:27pm
may include, among other things, statements that address our strategy and operating performance, events or developments that we expect or anticipate … , uncertainties and other important factors may include, among other things, statements which address our strategy and operating performance, events
8-K
EX-99.1
9zcf56f
31 Jul 23
Lexicon Elects Diane E. Sullivan to Board of Directors
4:02pm
424B5
bjoqgjy
1 Jun 23
Prospectus supplement for primary offering
9:08pm
424B5
qt5s1sab1z8gkt8wvmy
31 May 23
Prospectus supplement for primary offering
4:07pm
424B5
s3209nhgvj2pnfsi7
29 Jul 22
Prospectus supplement for primary offering
8:12am
424B5
cllbmkh n0js
27 Jul 22
Prospectus supplement for primary offering
5:30pm
8-K
EX-99.2
dg02l5qi
2 Aug 21
Lexicon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical Update
7:20am